Literature DB >> 7655987

Bradykinin-induced vasodilation is changed to a vasoconstrictor response in vessels of aged normotensive and hypertensive rats.

L Mantelli1, S Amerini, F Ledda.   

Abstract

The vascular response to bradykinin was investigated in mesenteric vascular bed preparations preconstricted with methoxamine, obtained from 2- and 18-month old normotensive (WKY) and spontaneously hypertensive (SHR) rats. In preparations from young normotensive rats bradykinin (1 nm-10 microM) produced an endothelium-dependent vasorelaxant effect which was greatly reduced by the B2 receptor antagonist Ac-D-Arg[Hyp3,D-Phe7,Leu8]-bradykinin (1 microM), and was unaffected by the B1 receptor antagonist des-Arg9,[Leu8]-bradykinin (1 microM). The degree of vasodilation was similar in preparations from age-matched SHR rats. In vessels obtained from old animals bradykinin induced an endothelium-independent vasoconstrictor response; this effect was more pronounced in preparations from SHR than in those from WKY rats. The vasoconstriction was unaffected by both B1 and B2 receptor antagonists, and was abolished by 3 microM indomethacin. We conclude that the vasorelaxant effect of bradykinin in vessels of young animals is due to stimulation of B2 receptors. This vasodilating response can be converted by aging to a vasoconstriction and is probably due to the release of a prostanoid product; moreover it is more pronounced in spontaneously hypertensive animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655987     DOI: 10.1007/bf01793215

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  19 in total

1.  Effect of protein kinase C and calcium on bradykinin-mediated contractions of rabbit vessels.

Authors:  J B Calixto; Y S Medeiros
Journal:  Hypertension       Date:  1992-02       Impact factor: 10.190

2.  De novo formation of vascular receptors for bradykinin.

Authors:  D Regoli; F Marceau; J Barabé
Journal:  Can J Physiol Pharmacol       Date:  1978-08       Impact factor: 2.273

3.  Bradykinin-induced vasoconstriction of rat mesenteric arteries precontracted with noradrenaline.

Authors:  J C Fasciolo; L Vargas; M C Lama; H Nolly
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide.

Authors:  D C Regoli; F Marceau; J Lavigne
Journal:  Eur J Pharmacol       Date:  1981-04-24       Impact factor: 4.432

5.  Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.

Authors:  L Levesque; G Drapeau; J H Grose; F Rioux; F Marceau
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

6.  Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo.

Authors:  J Bouthillier; D Deblois; F Marceau
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

7.  The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin.

Authors:  U Förstermann; G Hertting; B Neufang
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

8.  Characterization of endothelium-dependent relaxations resistant to nitro-L-arginine in the porcine coronary artery.

Authors:  T Nagao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

9.  Bradykinin: potential for vascular constriction in the presence of endothelial injury.

Authors:  V A Briner; P Tsai; R W Schrier
Journal:  Am J Physiol       Date:  1993-02

10.  Actions of bradykinin on isolated cerebral and peripheral arteries.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1977-03
View more
  1 in total

1.  Effects of chronic and acute aminoguanidine treatment on tail artery vasomotion in ageing rats.

Authors:  A Tabernero; S Nadaud; B Corman; J Atkinson; C Capdeville-Atkinson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.